Alcon AG | ALC - Beneficio Operativo





Beneficio Operativo Cambio Fecha
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 827M 2.7B 2026-06
Essilor EUR 2.3B 919M 2026-06
Fresenius EUR 719M 118M 2026-06
Fresenius Medical Care EUR 537.27M 269.27M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 329M 80M 2026-06
Lonza CHF 673M 243M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.75B 515M 2026-06
Philips EUR 610M 308M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
Smith & Nephew USD 505M 65M 2026-06
Sonova Holding CHF 296.8M 156.9M 2025-12
UCB EUR 1.29B 571M 2025-12